When Steve VanNurden, MBA, left the Mayo Clinic to join the University of Colorado Anschutz Medical Campus 12 years ago, Colorado was regarded as a “flyover state” in healthcare innovation. Today, it’s on the map as a recognized bioscience leader.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
This content is password protected. To view it please enter your password below: Password: The post Protected: CBSA Congratulates November 2025 Advanced Industries Accelerator Grant Recipients appeared first on Colorado Bioscience Association. Click here to […]
Welcome to Science Snapshot, a quick digest of the latest research happening across the CU Anschutz campus. Hear from researchers as they briefly explain one of their recent studies and how it could improve healthcare. […]
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive topline results from the Phase 2 CANYON trial of sevasemten in individuals with Becker muscular dystrophy. Sevasemten is an […]
Copyright © 2026 Biotech Networks
